Top Biotech Sectors
Performance and market cap breakdown across 20 biotech sectors.
Combined Sector Value
$17.1T
(includes overlap)Active Sectors
20 sectors
Top Mover Today
+0.78%Radiopharmaceuticals
| # | Sector | Market Cap | 1D % | 7D % | 30D % | Companies |
|---|---|---|---|---|---|---|
| 1 | 💊 Small Molecule Drugs2108 companies | $4.5T | -1.25% | -1.10% | -4.95% | 2108 |
| 2 | 🧬 Biologics / Biosimilars1421 companies | $4.2T | -1.49% | -1.55% | -5.86% | 1421 |
| 3 | 🧬 Digital Health & Biotech SaaS1551 companies | $1.8T | -1.67% | -2.47% | -7.80% | 1551 |
| 4 | 🔬 Cell & Gene Therapy772 companies | $1.2T | -0.79% | -2.35% | -7.66% | 772 |
| 5 | 🧪 RNA Therapeutics (non-mRNA)237 companies | $964.5B | -2.20% | -2.00% | +0.44% | 237 |
| 6 | 🔍 Diagnostics & Precision Medicine2262 companies | $960.6B | -1.64% | -1.28% | -7.60% | 2262 |
| 7 | 💉 Drug Delivery & Formulation1101 companies | $890.5B | -2.12% | -0.84% | +1.68% | 1101 |
| 8 | 🤖 AI / Machine Learning600 companies | $653.8B | -1.44% | -2.25% | -5.27% | 600 |
| 9 | 🎯 Oncology (General)950 companies | $447.1B | -2.03% | +0.15% | -1.96% | 950 |
| 10 | 🧬 mRNA Therapeutics33 companies | $292.9B | -1.69% | -1.36% | -6.94% | 33 |
| 11 | 🧬 Rare & Orphan Diseases239 companies | $292.2B | -0.34% | +0.79% | -0.78% | 239 |
| 12 | 🧬 Neuroscience & CNS657 companies | $237.9B | +0.74% | +3.26% | +3.17% | 657 |
| 13 | 🎯 Antibody-Drug Conjugates64 companies | $227.2B | -0.75% | -2.55% | -6.65% | 64 |
| 14 | 🧬 Proteomics & Protein Engineering229 companies | $115.9B | -1.94% | -1.83% | -4.09% | 229 |
| 15 | ✂️ CRISPR / Gene Editing84 companies | $113.2B | +0.20% | +1.25% | -2.23% | 84 |
| 16 | 🧬 Immunotherapy / Immuno-Oncology455 companies | $93.1B | -1.13% | -4.82% | -4.47% | 455 |
| 17 | 🧬 Regenerative Medicine454 companies | $83.9B | -0.85% | -1.86% | -6.05% | 454 |
| 18 | ⚗️ Synthetic Biology118 companies | $37.3B | -0.87% | -3.04% | -2.80% | 118 |
| 19 | 🧬 Radiopharmaceuticals75 companies | $11.7B | +0.78% | +7.70% | +15.28% | 75 |
| 20 | 🧬 Microbiome Therapeutics84 companies | $300.4M | -1.89% | +5.37% | +3.62% | 84 |